The closing price of Caredx Inc (NASDAQ: CDNA) was $9.89 for the day, down -2.47% from the previous closing price of $10.14. In other words, the price has decreased by -$0.25 from its previous closing price. On the day, 616655 shares were traded.
Ratios:
Our analysis of CDNA’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.77 and its Current Ratio is at 4.02. In the meantime, Its Debt-to-Equity ratio is 0.13 whereas as Long-Term Debt/Eq ratio is at 0.11.
On August 15, 2023, Raymond James Upgraded its rating to Outperform which previously was Mkt Perform but kept the price unchanged to $12.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Oct 02 ’23 when Seeto Reginald sold 2,818 shares for $6.91 per share. The transaction valued at 19,483 led to the insider holds 479,164 shares of the business.
Seeto Reginald sold 2,819 shares of CDNA for $26,762 on Sep 05 ’23. The insider now owns 481,982 shares after completing the transaction at $9.49 per share. On Aug 14 ’23, another insider, Seeto Reginald, who serves as the insider of the company, sold 576 shares for $8.89 each. As a result, the insider received 5,123 and left with 484,801 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CDNA now has a Market Capitalization of 525.03M and an Enterprise Value of 323.84M. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.83 while its Price-to-Book (P/B) ratio in mrq is 1.95. Its current Enterprise Value per Revenue stands at 1.16 whereas that against EBITDA is -3.81.
Stock Price History:
Over the past 52 weeks, CDNA has reached a high of $12.93, while it has fallen to a 52-week low of $4.80. The 50-Day Moving Average of the stock is 9.93, while the 200-Day Moving Average is calculated to be 9.01.
Shares Statistics:
CDNA traded an average of 1.02M shares per day over the past three months and 943.03k shares per day over the past ten days. A total of 51.50M shares are outstanding, with a floating share count of 49.43M. Insiders hold about 4.54% of the company’s shares, while institutions hold 99.21% stake in the company. Shares short for CDNA as of Feb 29, 2024 were 3.76M with a Short Ratio of 3.70, compared to 2.85M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 7.27% and a Short% of Float of 9.59%.
Earnings Estimates
The firm’s stock currently is rated by 5 analysts. On average, analysts expect EPS of -$0.19 for the current quarter, with a high estimate of -$0.17 and a low estimate of -$0.21, while EPS last year was -$0.11. The consensus estimate for the next quarter is -$0.14, with high estimates of -$0.09 and low estimates of -$0.18.
Analysts are recommending an EPS of between -$0.39 and -$0.68 for the fiscal current year, implying an average EPS of -$0.53. EPS for the following year is -$0.46, with 5 analysts recommending between -$0.19 and -$1.1.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 7 analysts. It ranges from a high estimate of $64.9M to a low estimate of $62M. As of the current estimate, Caredx Inc’s year-ago sales were $77.26M, an estimated decrease of -17.80% from the year-ago figure.
A total of 7 analysts have provided revenue estimates for CDNA’s current fiscal year. The highest revenue estimate was $269.06M, while the lowest revenue estimate was $264.1M, resulting in an average revenue estimate of $266.61M. In the same quarter a year ago, actual revenue was $280.32M, down -4.90% from the average estimate. Based on 6 analysts’ estimates, the company’s revenue will be $285.35M in the next fiscal year. The high estimate is $294.35M and the low estimate is $278.9M. The average revenue growth estimate for next year is up 7.00% from the average revenue estimate for this year.
